Login / Signup

Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study.

Sergey V MoiseevSergey AvdeevEkaterina TaoMichail BrovkoNikolay BulanovAnastasiia ZykovaLarisa AkulkinaIrina SmirnovaVictor Fomin
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • type diabetes
  • metabolic syndrome
  • disease activity
  • glycemic control